A review of the use of in silico methods to predict the chemistry of molecular initiating events related to drug toxicity

Author： Ellison Claire M Enoch Steven J Cronin Mark TD

Publisher： Informa Healthcare

ISSN： 1742-5255

Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.7, Iss.12, 2011-12, pp. : 1481-1495

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

In Vitro and In Silico Strategies to Identify OATP1B1 Inhibitors and Predict Clinical Drug–Drug Interactions

By Karlgren Maria Ahlin Gustav Bergström Christel Svensson Richard Palm Johan Artursson Per

Pharmaceutical Research, Vol. 29, Iss. 2, 2012-02 ,pp. : 411-426

Springer Publishing Company

Access to resources Recommend Favorite

In silico fragment-based drug design

By Konteatis Zenon D

Expert Opinion on Drug Discovery, Vol. 5, Iss. 11, 2010-11 ,pp. : 1047-1065

Informa Healthcare

Access to resources Recommend Favorite

High-throughput and in silico screenings in drug discovery

By Phatak Sharangdhar S Stephan Clifford C Cavasotto Claudio N

Expert Opinion on Drug Discovery, Vol. 4, Iss. 9, 2009-09 ,pp. : 947-959

Informa Healthcare

Access to resources Recommend Favorite

New in silico and conventional in vitro approaches to advance HIV drug discovery and design

By Maga Giovanni Veljkovic Nevena Crespan Emmanuele Spadari Silvio Prljic Jelena Perovic Vladimir Glisic Sanja Veljkovic Veljko

Expert Opinion on Drug Discovery, Vol. 8, Iss. 1, 2013-01 ,pp. : 83-92

Informa Healthcare

Access to resources Recommend Favorite

In silico analysis of antifungal peptides

By Soltani Saeed Keymanesh Keykhosrow Sardari Soroush

Expert Opinion on Drug Discovery, Vol. 2, Iss. 6, 2007-06 ,pp. : 837-847

Informa Healthcare

Access to resources Recommend Favorite